Dr. Marc Penn serves as medical advisor to Black Beret Life Sciences and its portfolio of companies. He is board certified in internal medicine and cardiovascular medicine, having earned his PhD in Biomedical Engineering in 1989 and Doctor of Medicine in 1994 at Case Western Reserve University in Cleveland, Ohio. Dr. Penn is a cardiologist and Director of Research and of the Cardiovascular Medicine Fellowship at the Summa Cardiovascular Institute, Summa Health (Akron, OH) and Professor of Medicine and Integrative Medical Sciences at Northeast Ohio Medical University where he leads the Skirball Laboratory for Cardiovascular Cellular Therapeutics (Rootstown, OH).
Previously Dr. Penn served in numerous cardiology positions with the Cleveland Clinic (2000-2011) where he was named one of the Top 50 Doctors in the History of the Cleveland Clinic (MedCity News, Dec. 2011). Dr. Penn’s extensive research background has led to key discoveries in cardiovascular medicine, and advances in diagnostics and drug delivery systems for CVD treatment, including strategies to optimize gene and stem cell therapy for regeneration of myocardial tissue. He is an active inventor and serial entrepreneur focused on the translation of scientific research to clinical populations.